October 20, 2021, Montreal – Children 12 years of age and under can now access extended half-life (EHL) factor IX in Quebec for the prophylactic...
Montreal, September 13, 2021 – In recent weeks, governments in both Quebec and the rest of Canada have expanded access to Hemlibra to patients with...
CLICK HERE to access the CHS 2020 Annual Report and the complete Financial Statements.
The Institut national d’excellence en santé et en services sociaux (INESSS) released its recommendation on funding Hemlibra (emicizumab) for the treatment of severe hemophilia A...
On November 2, 2020, the CHS held a live educational videoconference aimed to improve the understanding of FVIII/FIX inhibitors and treatment options, with a...